Uncategorized

October 12, 2010

Southwest Contractor Announces Best of 2010 New Mexico Award Winners

By

Southwest Contractor, a leading construction industry publication serving the Southwest since 1938, is pleased to announce the winners of its Best of 2010 Awards for New Mexico. The annual competition, now in its 13th year, recognizes construction and design excellence in separate award ceremonies for Arizona, Nevada and New Mexico.  Link

View full entry

Tags: In the News


October 6, 2010

Tough Enough to Wear Pink campaign raises awareness about breast cancer prevention

By

When the New Mexico State University Aggies play the University of New Mexico Lobos in the Battle of I-25 on Saturday, the fans at Aggie Memorial Stadium in Las Cruces will be divided over which team they want to win, but united in their support of breast cancer prevention at the fourth annual Tough Enough […]

View full entry

Tags: In the News


October 6, 2010

Events to benefit cancer research

By

Cowboys for Cancer Research invites all supporters and horse enthusiasts to dinner and dancing Friday and the 28th annual roping event Saturday and Sunday at Sproul Arena. All proceeds go directly to the University of New Mexico Cancer Center for cancer research and treatment. Link

View full entry

Tags: In the News


October 5, 2010

Cowboys For Cancer Research continues to raise money

By

Denny Calhoun is unabashed and readily admits that cowboys do indeed wear pink. Calhoun was wearing a red shirt when he said that. But Calhoun’s western shirt was embroidered with the Cowboys For Cancer Research emblem, and there was embroidery on the back that let people clearly know he could give them more information about […]

View full entry

Tags: In the News


October 4, 2010

Higher Dose of Faslodex® More Effective for Advanced Breast Cancer

By

Among postmenopausal women with advanced, estrogen receptor-positive breast cancer that has progressed or recurred after prior hormonal therapy, a 500 mg dose of Faslodex® (fulvestrant) appears to be more effective than the originally approved 250 mg dose. These results were published in the Journal of Clinical Oncology. As a result of these findings, the 500 […]

View full entry

Tags: UNM CC Features


September 24, 2010

NCI Launches Next Phase of Alliance for Nanotechnology in Cancer Program

By

The National Cancer Institute (NCI) has awarded five-year, multi-institution grants in continued support of its Alliance for Nanotechnology in Cancer program. The Alliance is engaged in efforts to leverage the specific advantages of nanotechnology to improve the way we diagnose, treat, and prevent cancer. Researchers involved in the program have developed a host of novel […]

View full entry

Tags: In the News


September 22, 2010

Multivitamins Don’t Improve Colon Cancer Outcomes

By

In a study of patients with Stage III colon cancer, use of multivitamins during and after chemotherapy did not improve survival or reduce the risk of recurrence. These results were published in the Journal of Clinical Oncology. Stage III colon cancer refers to cancer that has spread to lymph nodes surrounding the colon but not […]

View full entry

Tags: UNM CC Features


September 1, 2010

New Mexico’s Largest Cancer Fund Raiser to Hold Dinner, Dance, and Team Roping Competition

By

Cowboys for Cancer Research, a not-for-profit group organized to fund cancer research, will host the 28th Annual Dinner, Dance and Team Roping competition between October 8 and 10, 2010 in Las Cruces. The three-day event traditionally raises hundreds of thousands of dollars for collaborative cancer research projects at the UNM Cancer Center and New Mexico […]

View full entry

Tags: News and Events


August 30, 2010

Lunch and CLE

By

The Albuquerque Bar Association will hold a lunch/CLE at 11:45 a.m., Sept. 24, at the UNM Cancer Center, 1201 Camino De Salud NE, Albuquerque. Boxed lunches will be provided by the Jeff Diamond Law Firm on behalf of the Shannon J. Shaw Memorial Cancer Fund at the UNM Cancer Center. Free parking will also be […]

View full entry

Tags: In the News


August 27, 2010

Oncology Care Live, Continuing Medical Education Congress Presented by the Johns Hopkins University School of Medicine, to Meet Live Online September 29th and 30th

By

Oncology Care Live, the live online oncology congress presented by the Johns Hopkins University School of Medicine, today announced speakers and a preliminary agenda for the September 29th to 30th live online event, a Continuing Medical Education (CME) program that features live video presentations in a variety of formats, including case studies, roundtables and panel […]

View full entry

Tags: In the News


August 27, 2010

Reduced-intensity Treatment May be Effective for Early Hodgkin’s Lymphoma

By

Among patients with early-stage Hodgkin’s lymphoma and a favorable prognosis, it may be possible to reduce the number of chemotherapy cycles and the dose of radiation therapy without adversely affecting outcome. The results of this study were published in the New England Journal of Medicine. Hodgkin’s lymphoma is a cancer of the lymph system and […]

View full entry

Tags: UNM CC Features


August 23, 2010

Physician, Heal Thyself and Elderly Patients

By

Call it the Death Panel without the panel.  A study by University of New Mexico Cancer Center researchers shows oncologists didn’t routinely give elderly leukemia patients a drug that increases their chances of survival nearly sixfold. Even though it has minor side effects. And even though seniors with chronic myeloid leukemia are the best candidates […]

View full entry

Tags: In the News


August 20, 2010

Older population missing out on life saving cancer drug

By

When it was approved by the FDA in 2001, imatinib, or GLEEVEC, was billed as a wonder drug that could help patients with chronic myeloid leukemia (CML), a fatal disease, live. A new study by researchers at the University of New Mexico’s Cancer Center has borne that out. Imatinib stops the leukemia in its tracks. […]

View full entry

Tags: In the News


August 19, 2010

Study: Revolutionary cancer drug not reaching elderly patients

By

When Dr. Robert Hromas’ father was diagnosed with chronic myeloid leukemia, Hromas immediately prescribed him the revolutionary cancer treatment drug called Gleevec (or imatinib) — which is widely considered the most effective treatment for this type of cancer. Leslie Hromas is now 80 and is in complete remission. Other elderly patients with CML are not […]

View full entry

Tags: In the News


August 19, 2010

Study: Some cancer patients not given drug

By

Many elderly U.S. cancer patients were not given a drug that could improve chances of survival sixfold out of concern for minor side effects, a study says. Researchers at the University of New Mexico Cancer Center say oncologists showed reluctance to prescribe the drug imatinib for older sufferers of chronic myeloid leukemia, a relatively rare […]

View full entry

Tags: In the News